These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 2119263)

  • 1. Significance of initial ST segment elevation and depression for the management of thrombolytic therapy in acute myocardial infarction. European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator.
    Willems JL; Willems RJ; Willems GM; Arnold AE; Van de Werf F; Verstraete M
    Circulation; 1990 Oct; 82(4):1147-58. PubMed ID: 2119263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of electrocardiographic scoring systems for the assessment of thrombolytic therapy in acute myocardial infarction. The European Cooperative Study Group for Recombinant Tissue Type Plasminogen Activator.
    Willems JL; Willems RJ; Bijnens I; Doerr R; Verstraete M
    Eur Heart J; 1991 Mar; 12(3):378-88. PubMed ID: 1904028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.
    Van de Werf F; Arnold AE
    BMJ; 1988 Nov; 297(6660):1374-9. PubMed ID: 3146370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute coronary artery obstruction in myocardial infarction: overview of thrombolytic therapy.
    Hugenholtz PG
    J Am Coll Cardiol; 1987 Jun; 9(6):1375-84. PubMed ID: 3108346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of admission electrocardiogram in predicting outcome of thrombolytic therapy in acute myocardial infarction. A randomized trial conducted by The Netherlands Interuniversity Cardiology Institute.
    Bar FW; Vermeer F; de Zwaan C; Ramentol M; Braat S; Simoons ML; Hermens WT; van der Laarse A; Verheugt FW; Krauss XH
    Am J Cardiol; 1987 Jan; 59(1):6-13. PubMed ID: 3544782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of precordial ST segment depression on admission electrocardiogram in patients with inferior wall myocardial infarction.
    Birnbaum Y; Herz I; Sclarovsky S; Zlotikamien B; Chetrit A; Olmer L; Barbash GI
    J Am Coll Cardiol; 1996 Aug; 28(2):313-8. PubMed ID: 8800103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terminal QRS distortion on admission is better than ST-segment measurements in predicting final infarct size and assessing the Potential effect of thrombolytic therapy in anterior wall acute myocardial infarction.
    Birnbaum Y; Maynard C; Wolfe S; Mager A; Strasberg B; Rechavia E; Gates K; Wagner GS
    Am J Cardiol; 1999 Sep; 84(5):530-4. PubMed ID: 10482150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring Substudy.
    Langer A; Krucoff MW; Klootwijk P; Simoons ML; Granger CB; Barr A; Califf RM; Armstrong PW
    J Am Coll Cardiol; 1998 Mar; 31(4):783-9. PubMed ID: 9525547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late assessment of thrombolytic efficacy (LATE) study: prognosis in patients with non-Q wave myocardial infarction. (LATE Study Investigators).
    Langer A; Goodman SG; Topol EJ; Charlesworth A; Skene AM; Wilcox RG; Armstrong PW
    J Am Coll Cardiol; 1996 May; 27(6):1327-32. PubMed ID: 8626939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrocardiographic and enzymatic infarct size in a randomised study of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Hackworthy RA; Sorensen SG; Menlove RL; Anderson JL
    Drugs; 1987; 33 Suppl 3():198-208. PubMed ID: 3315592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrocardiographic evidence of myocardial salvage after thrombolysis in acute myocardial infarction.
    Hogg KJ; Lees KR; Hornung RS; Howie CA; Dunn FG; Hillis WS
    Br Heart J; 1989 Jun; 61(6):489-95. PubMed ID: 2667593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extent of ST-segment deviation in the single ECG lead of maximum deviation present 90 or 180 minutes after start of thrombolytic therapy best predicts outcome in acute myocardial infarction.
    Schröder K; Wegscheider K; Zeymer U; Neuhaus KL; Schröder R
    Z Kardiol; 2001 Aug; 90(8):557-67. PubMed ID: 11565211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction. The Tissue Plasminogen Activator: Toronto (TPAT) Study Group.
    Langer A; Minkowitz J; Dorian P; Casella L; Harris L; Morgan CD; Armstrong PW
    J Am Coll Cardiol; 1992 Nov; 20(6):1313-7. PubMed ID: 1430680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rescue thrombolysis: alteplase as adjuvant treatment after streptokinase in acute myocardial infarction.
    Mounsey JP; Skinner JS; Hawkins T; MacDermott AF; Furniss SS; Adams PC; Kesteven PJ; Reid DS
    Br Heart J; 1995 Oct; 74(4):348-53. PubMed ID: 7488444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early ST-segment recovery, infarct artery blood flow, and long-term outcome after acute myocardial infarction.
    French JK; Andrews J; Manda SO; Stewart RA; McTigue JJ; White HD
    Am Heart J; 2002 Feb; 143(2):265-71. PubMed ID: 11835029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial.
    Schröder R; Wegscheider K; Schröder K; Dissmann R; Meyer-Sabellek W
    J Am Coll Cardiol; 1995 Dec; 26(7):1657-64. PubMed ID: 7594100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators.
    Goodman SG; Langer A; Ross AM; Wildermann NM; Barbagelata A; Sgarbossa EB; Wagner GS; Granger CB; Califf RM; Topol EJ; Simoons ML; Armstrong PW
    Circulation; 1998 Feb; 97(5):444-50. PubMed ID: 9490238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase?
    Vermeer F; Simoons ML; Bär FW; Tijssen JG; van Domburg RT; Serruys PW; Verheugt FW; Res JC; de Zwaan C; van der Laarse A
    Circulation; 1986 Dec; 74(6):1379-89. PubMed ID: 3779921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression: immediate and long-term results of a randomized study.
    Ribichini F; Steffenino G; Dellavalle A; Ferrero V; Vado A; Feola M; Uslenghi E
    J Am Coll Cardiol; 1998 Nov; 32(6):1687-94. PubMed ID: 9822097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial Infarction.
    Barbash GI; Roth A; Hod H; Miller HI; Rath S; Har-Zahav Y; Modan M; Seligsohn U; Battler A; Kaplinsky E
    Br Heart J; 1990 Oct; 64(4):241-7. PubMed ID: 2121199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.